表紙
市場調查報告書
商品編碼
1028931

全球生物相似藥單株抗體市場報告:2021年版 - COVID-19擴大和到2030年前的變化

Biosimilar Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球生物相似藥單株抗體市場相關調查,網羅市場特性,規模與成長,市場區隔,各地各國趨勢,競爭情形,市場佔有率,市場趨勢與策略。還有各地區的市場的實際成果與預測,及加入此市場的主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 生物相似藥單株抗體市場特徵

第3章 生物相似藥單株抗體的市場趨勢與策略

第4章 COVID-19對生物相似藥單株抗體的影響

第5章 生物相似藥單株抗體的市場規模與成長

  • 全球生物相似藥單株抗體市場實際成果,2015∼2020年,10億美元
    • 市場促進因素
    • 市場阻礙因素
  • 全球生物相似藥單株抗體市場預測,2020∼2025年,2030年,10億美元
    • 市場促進因素
    • 市場阻礙因素

第6章 生物相似藥單株抗體的市場細分化

  • 全球生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 合成化學物質
  • 生物醫藥品
  • 其他
  • 全球生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 慢性及自體免疫疾病
  • 腫瘤學
  • 其他
  • 全球生物相似藥單株抗體市場,各化合物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • Infliximab
  • Rituximab
  • Abciximab
  • Trastuzumab
  • Adalimumab
  • Bevacizumab

第7章 生物相似藥單株抗體市場各地區以及各國分析

  • 全球生物相似藥單株抗體市場,各地區,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 全球生物相似藥單株抗體市場,各國,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第8章 亞太地區的生物相似藥單株抗體市場

  • 亞太地區的生物相似藥單株抗體市場概要
  • 地區資訊,COVID-19的影響,市場資訊,背景資訊,政府的積極推動,法規,法規機關,主要的協會,免稅,公司稅結構,投資,主要企業
  • 亞太地區的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 亞太地區的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第9章 中國的生物相似藥單株抗體市場

  • 中國的生物相似藥單株抗體市場概要
  • 中國的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 中國的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第10章 印度的生物相似藥單株抗體市場

  • 印度的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 印度的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第11章 日本的生物相似藥單株抗體市場

  • 日本的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 日本的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第12章 澳洲的生物相似藥單株抗體市場

  • 澳洲的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 澳洲的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第13章 印尼的生物相似藥單株抗體市場

  • 印尼的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 印尼的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第14章 韓國的生物相似藥單株抗體市場

  • 韓國的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 韓國的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第15章 西歐的生物相似藥單株抗體市場

  • 西歐的生物相似藥單株抗體市場概要
  • 西歐的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 西歐的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第16章 英國的生物相似藥單株抗體市場

  • 英國的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 英國的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第17章 德國的生物相似藥單株抗體市場

  • 德國的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 德國的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第18章 法國的生物相似藥單株抗體市場

  • 法國的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 法國的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第19章 東歐的生物相似藥單株抗體市場

  • 東歐的生物相似藥單株抗體市場概要
  • 東歐的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 東歐的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第20章 俄羅斯的生物相似藥單株抗體市場

  • 俄羅斯的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 俄羅斯的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第21章 北美的生物相似藥單株抗體市場

  • 北美的生物相似藥單株抗體市場概要
  • 北美的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 北美的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第22章 美國的生物相似藥單株抗體市場

  • 美國的生物相似藥單株抗體市場概要
  • 美國的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 美國的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第23章 南美的生物相似藥單株抗體市場

  • 南美的生物相似藥單株抗體市場概要
  • 南美的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 南美的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第24章 巴西的生物相似藥單株抗體市場

  • 巴西的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 巴西的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第25章 中東的生物相似藥單株抗體市場

  • 中東的生物相似藥單株抗體市場概要
  • 中東的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 中東的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第26章 非洲的生物相似藥單株抗體市場

  • 非洲的生物相似藥單株抗體市場概要
  • 非洲的生物相似藥單株抗體市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 非洲的生物相似藥單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第27章 生物相似藥單株抗體市場競爭情形和企業簡介

  • 生物相似藥單株抗體市場競爭情形
  • 生物相似藥單株抗體市場企業簡介
    • Pfizer
    • Novartis
    • Allergan
    • Coherus BioSciences
    • Biocon

第28章 生物相似藥單株抗體開發平台分析

第29章 生物相似藥單株抗體市場上主要合併和收購

第30章 生物相似藥單株抗體市場未來展望和潛在性分析

第31章 附錄

目錄
Product Code: h956

Biosimilar Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar monoclonal antibodies market.

This report focuses on biosimilar monoclonal antibodies market which is experiencing strong growth. The report gives a guide to the biosimilar monoclonal antibodies market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the biosimilar monoclonal antibodies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biosimilar Monoclonal Antibodies market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider biosimilar monoclonal antibodies market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biosimilar monoclonal antibodies market section of the report gives context. It compares the biosimilar monoclonal antibodies market with other segments of the biosimilar monoclonal antibodies market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biosimilar monoclonal antibodies indicators comparison.

Scope

Markets Covered: 1) By Type: Synthetic Chemicals; Biopharmaceuticals; Others

2) By Application: Chronic & Autoimmune Diseases; Oncology; Others

3) By Compound: Infliximab; Rituximab; Abciximab; Trastuzumab; Adalimumab; Bevacizumab

Companies Mentioned: Pfizer; Novartis; Allergan; Coherus BioSciences; Biocon

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Biosimilar Monoclonal Antibodies Market Characteristics

3. Biosimilar Monoclonal Antibodies Market Trends And Strategies

4. Impact Of COVID-19 On Biosimilar Monoclonal Antibodies

5. Biosimilar Monoclonal Antibodies Market Size And Growth

  • 5.1. Global Biosimilar Monoclonal Antibodies Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Biosimilar Monoclonal Antibodies Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Biosimilar Monoclonal Antibodies Market Segmentation

  • 6.1. Global Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Synthetic Chemicals
  • Biopharmaceuticals
  • Others
  • 6.2. Global Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Chronic & Autoimmune Diseases
  • Oncology
  • Others
  • 6.3. Global Biosimilar Monoclonal Antibodies Market, Segmentation By Compound, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Infliximab
  • Rituximab
  • Abciximab
  • Trastuzumab
  • Adalimumab
  • Bevacizumab

7. Biosimilar Monoclonal Antibodies Market Regional And Country Analysis

  • 7.1. Global Biosimilar Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Biosimilar Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Biosimilar Monoclonal Antibodies Market

  • 8.1. Asia-Pacific Biosimilar Monoclonal Antibodies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Biosimilar Monoclonal Antibodies Market

  • 9.1. China Biosimilar Monoclonal Antibodies Market Overview
  • 9.2. China Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Biosimilar Monoclonal Antibodies Market

  • 10.1. India Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Biosimilar Monoclonal Antibodies Market

  • 11.1. Japan Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Biosimilar Monoclonal Antibodies Market

  • 12.1. Australia Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Biosimilar Monoclonal Antibodies Market

  • 13.1. Indonesia Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Biosimilar Monoclonal Antibodies Market

  • 14.1. South Korea Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Biosimilar Monoclonal Antibodies Market

  • 15.1. Western Europe Biosimilar Monoclonal Antibodies Market Overview
  • 15.2. Western Europe Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Biosimilar Monoclonal Antibodies Market

  • 16.1. UK Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Biosimilar Monoclonal Antibodies Market

  • 17.1. Germany Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Biosimilar Monoclonal Antibodies Market

  • 18.4. France Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Biosimilar Monoclonal Antibodies Market

  • 19.1. Eastern Europe Biosimilar Monoclonal Antibodies Market Overview
  • 19.2. Eastern Europe Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Biosimilar Monoclonal Antibodies Market

  • 20.1. Russia Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Biosimilar Monoclonal Antibodies Market

  • 21.1. North America Biosimilar Monoclonal Antibodies Market Overview
  • 21.2. North America Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Biosimilar Monoclonal Antibodies Market

  • 22.1. USA Biosimilar Monoclonal Antibodies Market Overview
  • 22.2. USA Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Biosimilar Monoclonal Antibodies Market

  • 23.1. South America Biosimilar Monoclonal Antibodies Market Overview
  • 23.2. South America Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Biosimilar Monoclonal Antibodies Market

  • 24.1. Brazil Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Biosimilar Monoclonal Antibodies Market

  • 25.1. Middle East Biosimilar Monoclonal Antibodies Market Overview
  • 25.2. Middle East Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Biosimilar Monoclonal Antibodies Market

  • 26.1. Africa Biosimilar Monoclonal Antibodies Market Overview
  • 26.2. Africa Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Biosimilar Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Biosimilar Monoclonal Antibodies Market Competitive Landscape And Company Profiles

  • 27.1. Biosimilar Monoclonal Antibodies Market Competitive Landscape
  • 27.2. Biosimilar Monoclonal Antibodies Market Company Profiles
    • 27.2.1. Pfizer
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Novartis
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Allergan
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Coherus BioSciences
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Biocon
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Biosimilar Monoclonal Antibodies Pipeline Analysis

29. Key Mergers And Acquisitions In The Biosimilar Monoclonal Antibodies Market

30. Biosimilar Monoclonal Antibodies Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer